API
If you are interested, please contact us.
E-mail: 2nd_sales@carelife-cn.com
Tel: +86-23-63117967
*The following content is generated by AI and is for reference only.
Overview
Bortezomib is a proteasome inhibitor used in oncology. Its molecular formula is C21H29N4O6P, and the CAS number is 179324-69-7.
Application
- Hematologic Malignancies: First-line treatment for Multiple Myeloma and Mantle Cell Lymphoma.
- Clinical Trials: Investigated for solid tumors and combination therapies with immunomodulators.
Precautions
Requires strict temperature control at -20°C. Handling demands PPE due to cytotoxicity; monitor for peripheral neuropathy and thrombocytopenia during administration.